Loading company…
Norry-Biotech develops radiopharmaceuticals and platforms for nuclear medicine research and production.
Established in 2021 in Wuxi, Norry-Biotech researches and develops radiopharmaceuticals, including candidates for pancreatic, kidney, stomach, ovarian, and prostate cancers. It operates research, production, screening, and imaging platforms, with the affiliated Hospital of Jiangnan University. In February 2028, the company raised Series A+ funding from Xinghua Dingli Capital to advance nuclear medicine products for conditions including kidney and gastric cancer.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in